Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohito Okano

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Advances in Respiratory Medicine|February 20, 2026
Neutralization of Microbiota-Derived Corisin Shows Early Amelioration of Advanced Pulmonary FibrosisKazuki Furuhashi, Hajime Fujimoto, Masaaki Toda, et al.
Frontiers in Immunology|August 21, 2019
Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial AsthmaYoshinori Takahashi, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Allergy|March 8, 2020
Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balanceKentaro Asayama, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Frontiers in Pharmacology|January 4, 2021
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung FibrosisTomohito Okano, Tetsu Kobayashi, Taro Yasuma, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2024
Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infectionTatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, et al.
Cells|September 27, 2024
Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human <i>MUC5B</i> rs35705950 VariantSuphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, et al.
Cancer Medicine|April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitorsTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancers|August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and ChemotherapyTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Nature Communications|March 24, 2022
Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosisCorina N D'Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, et al.
Nature Communications|August 25, 2025
Microbiota-derived corisin accelerates kidney fibrosis by promoting cellular agingTaro Yasuma, Hajime Fujimoto, Corina N D'Alessandro-Gabazza, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Advances in Respiratory Medicine|February 20, 2026
Neutralization of Microbiota-Derived Corisin Shows Early Amelioration of Advanced Pulmonary FibrosisKazuki Furuhashi, Hajime Fujimoto, Masaaki Toda, et al.
Frontiers in Immunology|August 21, 2019
Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial AsthmaYoshinori Takahashi, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Allergy|March 8, 2020
Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balanceKentaro Asayama, Tetsu Kobayashi, Corina N D'Alessandro-Gabazza, et al.
Frontiers in Pharmacology|January 4, 2021
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorβ1-Driven Lung FibrosisTomohito Okano, Tetsu Kobayashi, Taro Yasuma, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2024
Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infectionTatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, et al.
Cells|September 27, 2024
Bleomycin-Induced Pulmonary Fibrosis in Transgenic Mice Carrying the Human <i>MUC5B</i> rs35705950 VariantSuphachai Tharavecharak, Hajime Fujimoto, Taro Yasuma, et al.
Cancer Medicine|April 17, 2024
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitorsTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Cancers|August 26, 2022
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and ChemotherapyTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Nature Communications|March 24, 2022
Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosisCorina N D'Alessandro-Gabazza, Taro Yasuma, Tetsu Kobayashi, et al.
Nature Communications|August 25, 2025
Microbiota-derived corisin accelerates kidney fibrosis by promoting cellular agingTaro Yasuma, Hajime Fujimoto, Corina N D'Alessandro-Gabazza, et al.
Pageof 3